Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children

Abstract

Objectives Cirrhotic children wait‐listed for liver transplant are prone to bleeding from gastrointestinal varices. Grade 2‐3 esophageal varices, red signs, and gastric varices are well‐known risk factors. However, the involvement of hemostatic factors remains controversial because of the rebalanced state of coagulation during cirrhosis. Methods Children suffering from decompensated cirrhosis were prospectively included while being on waitlist. Portal hypertension was assessed by ultrasound and endoscopy. Coagulopathy was evaluated through conventional tests, thromboelastometry, and platelet function testing. The included children were followed up until liver transplantation, and all bleeding episodes were recorded. Children with or without bleeding were compared according to clinical, radiological, endoscopic, and biological parameters. In addition, validation of a predictive model for risk of variceal bleeding comprising of grade 2‐3 esophageal varices, red spots, and fibrinogen level <150 mg/dL was applied on this cohort. Results Of 20 enrolled children, 6 had upper gastrointestinal bleeding. Significant differences were observed in fibrinogen level, adenosine diphosphate, and thrombin‐dependent platelet aggregation. The model used to compute the upper gastrointestinal bleeding risk had an estimated predictive performance of 81.0%. Platelet aggregation analysis addition improved the estimated predictive performance up to 89.0%. Conclusions We demonstrated an association between hemostatic factors and the upper gastrointestinal bleeding risk. A low fibrinogen level and platelet aggregation dysfunction may predict the risk of bleeding in children with decompensated cirrhosis. A predictive model is available to assess the upper gastrointestinal bleeding risk but needs further investigations. Clinicaltrials.gov number: NCT03244332

Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?

“…Curiously, patients with PVT had decreased platelet aggregation compared to patients without PVT (platelet count was similar between groups). In a pediatric cohort of decompensated cirrhotic children, we also highlighted decreased platelet aggregation [51]. Although not corrected for platelet count, aggregation was lower in children presenting with upper gastrointestinal bleeding.…”

Noninvasive markers for esophageal varices in children with cirrhosis

“…A recent study has highlighted the use of hemostatic markers for predicting upper gastrointestinal bleeding in children with cirrhosis. 6) Moreover, end-stage liver disease models, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ratio, AST to platelet ratio index (APRI), platelet count to spleen diameter (PC/SD) have been studied as noninvasive markers for EV in several studies. 7) Nonetheless, due to controversies, clinical applications of these markers are still unknown.…”

The use of prothrombin complex concentrate in chronic liver disease: A review of the literature

“…2,3 The study of platelet function is much more complex and conflicting reports exist. 4,5 Some describe decreased platelet function 6,7 while others report enhanced platelet activation. 3,8 Fibrinogen plays a role in both primary haemostasis (platelet aggregation) and coagulation (fibrin formation).…”